Skip to content

Contract award record

NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023

Tender value £264,003,000

Notice details

Published
Category
goods
Buyer region
North West

Public buyer and contract winner

Public buyer

NHS England
awarded to

Contract winner

Amgen Ltd

Award value£264,003,228

  1. Awarded
    Completed
  2. Start
    Completed
  3. End
    Completed

Work description

Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023

Offer reference number: CM/PHR/22/5660

CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to the North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Related awards

Source: Contracts Finder · Notice a6b9f437-01c6-49a7-a10f-e629b7cdf660-627683

View source notice